Living Between Relapses
Multiple sclerosis rarely announces itself all at once. A bout of blurred vision that resolves. Numbness in a hand that fades. Fatigue that never fully lifts. Then a relapse arrives that does not fully reverse, and the question changes from what is happening to me to what can I actually do about it.
Many people reach that question after years on disease-modifying therapy, still watching their function slip. That is usually when stem cell therapy for multiple sclerosis enters the search history.
This guide separates the two very different things that phrase can mean, explains what the evidence supports, and is direct about what it does not.
What Multiple Sclerosis Actually Does
MS is an autoimmune condition in which the immune system attacks myelin, the protective coating around nerve fibres in the brain and spinal cord. Signals slow or fail, producing symptoms that depend on where the damage sits: vision problems, numbness, weakness, balance issues, bladder problems and fatigue.
The two patterns that matter most for treatment decisions are:
- •Relapsing-remitting MS: clear attacks with recovery in between, driven by active inflammation
- •Progressive MS: steady worsening with less obvious inflammatory activity, which responds less to immune-targeted treatment
This distinction drives everything that follows, because immune-resetting treatments work best where inflammation is active.
Standard Care Is the Foundation
Modern disease-modifying therapies have transformed MS. They reduce relapse rates, limit new MRI lesions and slow disability, and starting them early matters. Physiotherapy, symptom management and lifestyle measures such as exercise and not smoking add real, proven benefit.
Nothing in this article replaces that foundation. Any regenerative approach belongs alongside your neurologist's plan, and stopping disease-modifying therapy to pursue unproven treatment is one of the most dangerous decisions an MS patient can make.
Stem Cell Therapy for Multiple Sclerosis: What the Evidence Shows
The phrase covers two very different procedures. Haematopoietic stem cell transplantation, or HSCT, uses chemotherapy to suppress the faulty immune system and then rebuilds it from the patient's own blood stem cells. In carefully selected patients with highly active relapsing MS, trials show it can halt disease activity for years in a substantial proportion. It is also a demanding hospital procedure with genuine risk, delivered by transplant specialists.
Mesenchymal stem cell therapy is different: gentler, given by infusion, and aimed at calming inflammation and supporting the repair environment rather than resetting the immune system. Early studies suggest it is generally safe and may help some measures, but the evidence is not yet strong enough to call it established care. It remains investigational.
For the broader autoimmune context, see stem cell therapy for autoimmune conditions and our neurological treatment programmes.
Comparing the Options
| Approach | Evidence level | Best fit |
|---|---|---|
| Disease-modifying therapy | Strong, established | Nearly everyone with MS |
| HSCT (immune reset) | Substantial trial evidence in selected patients | Highly active relapsing MS despite medication |
| MSC therapy | Early, investigational | Considered case by case alongside standard care |
| Rehabilitation and lifestyle | Proven supportive benefit | Everyone, at every stage |
MS Assessment in Thailand at MRC Healthcare
At MRC Healthcare, an MS enquiry begins with a careful review: your diagnosis, MRI history, relapse pattern and current disease-modifying therapy. We communicate with your neurologist where possible, and if regenerative support is not appropriate for your situation, we will say so plainly.
Where it is considered, cell preparation takes place in our certified laboratory, and goals are defined in advance: what improvement would look like, over what period, and how it will be judged.
For Patients Travelling from Abroad
Patients visit our Bangkok facility from Australia, Singapore, Europe and beyond. MRI reports and treatment history can be reviewed in advance, and a first consultation can often begin remotely, so travel is only planned once there is a clear reason for it.
English-speaking coordination is available throughout, including planning around mobility needs and the length of stay your assessment requires.
Medical References
- NHS. Multiple sclerosis: symptoms, causes and treatment
- National MS Society. Research and treatment resources
- International Society for Stem Cell Research. Guidelines for Stem Cell Research and Clinical Translation
Get a Straight Answer About Your MS
Send your diagnosis and MRI history to MRC Healthcare. Our medical team will tell you honestly what stem cell therapy for multiple sclerosis could and could not offer in your situation, including when the answer is that it is not appropriate.
Schedule a Consultation





